Werbung
Werbung
NRIX
Nurix Therapeutics, Inc. Common stock
19.30
USDGesponsert
+0.66
+3.56%
09. Jan., 15:59 UTC -5
Geschlossen
Vor-Markt
19.33
+0.03
+0.16%
NRIX Ergebnisberichte
Positives Überraschungsverhältnis
NRIX übertreffen die 9 der letzten 21Schätzungen.
43%
Nächster Bericht
Datum des nächsten Berichts
26. Jan. 2026
Estimate for Q4 25 (Revenue/ EPS)
$14.60M
/-$0.90
Implizierte Änderung von Q3 25 (Revenue/ EPS)
+84.89%
/-12.62%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
+9.87%
/+20.00%
Nurix Therapeutics, Inc. Common stock earnings per share and revenue
On 09. Okt. 2025, NRIX reported earnings of -1.03 USD per share (EPS) for Q3 25, missing the estimate of -0.85 USD, resulting in a -20.05% surprise. Revenue reached 7.89 million, compared to an expected 17.07 million, with a -53.76% difference. The market reacted with a -10.13% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 19 analysts forecast an EPS of -0.90 USD, with revenue projected to reach 14.60 million USD, implying an decrease of -12.62% EPS, and increase of 84.89% in Revenue from the last quarter.
FAQ
What were Nurix Therapeutics, Inc. Common stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Nurix Therapeutics, Inc. Common stock reported EPS of -$1.03, missing estimates by -20.05%, and revenue of $7.89M, -53.76% below expectations.
How did the market react to Nurix Therapeutics, Inc. Common stock's Q3 2025 earnings?
The stock price moved down -10.13%, changed from $10.86 before the earnings release to $9.76 the day after.
When is Nurix Therapeutics, Inc. Common stock expected to report next?
The next earning report is scheduled for 26. Jan. 2026.
What are the forecasts for Nurix Therapeutics, Inc. Common stock's next earnings report?
Based on 19
analysts, Nurix Therapeutics, Inc. Common stock is expected to report EPS of -$0.90 and revenue of $14.60M for Q4 2025.
Which companies are reporting earnings today?
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung